Product Information

TIAZAC ER 180 MG CAPSULE is a brand product labeled by Bausch Health US LLC, priced at $1.5060 per EA under NDC 00187261330. Its NADAC has been published 41 times since Dec 10, 2014.

FDA first approved this application on Sep 11, 1995. Its Orange Book therapeutic-equivalence code is AB4 — FDA rates it therapeutically equivalent to (substitutable for) its reference product.

The High Outlier badge above means this manufacturer's average price in the diltiazem hydrochloride market falls above Q3 + 1.5·IQR across all competing manufacturers. We only apply this flag in markets with four or more competitors. Full definition: glossary → outlier.

Price Statistics

The NADAC for TIAZAC ER 180 MG CAPSULE has been published 41 times since Dec 10, 2014, and over the history we have for it it has held within roughly two percent of its current level. The table below summarizes its recorded NADAC range and movement.

Generic Alternatives

The matcher finds 4 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 90% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.